Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab

INTRODUCTION: Infliximab is an effective treatment for inflammatory bowel disease (IBD). Studies differ regarding the influence of body mass index (BMI) on the response to infliximab, with the majority of studies indicating that increased BMI may be associated with a poorer response to Infliximab. H...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Scaldaferri, Franco, D‘Ambrosio, Daria, Holleran, Grainne, Poscia, Andrea, Petito, Valentina, Lopetuso, Loris, Graziani, Cristina, Laterza, Lucrezia, Pistone, Maria Teresa, Pecere, Silvia, Currò, Diego, Gaetani, Eleonora, Armuzzi, Alessandro, Papa, Alfredo, Cammarota, Giovanni, Gasbarrini, Antonio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657978/
https://ncbi.nlm.nih.gov/pubmed/29073159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0186575
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia